Clinical Information
patient
|
XJ1137816 |
Age
|
63 |
Gender
|
M |
Genotype
|
None |
Diagnosis
|
hepatocellular carcinoma |
HBV DNA
|
664IU/ml |
HBeAg
|
0 |
AFP(ng/ml)
|
418.9 |
PLT(log IU/mL)
|
231 |
HBcAb
|
1 |
HBsAb
|
0 |
HBeAb
|
0 |
HBsAg
|
1 |
ctDNA concentration
|
0.01387 |
marker
|
ctDNA- |
Hospital
|
Zhongshan Hospital, Fudan University, Shanghai |
HBsAg (IU/ml)
|
189.4 |
BCLC
|
B |
ACJJ
|
IIIA |
Tumor maximum size
|
6 |
Tumor count
|
2 |
MVI
|
M0 |
PIVKA-II (mAU/ml)
|
3179 |
CA199 (U/ml)
|
25.1 |
Cirrhosis history
|
0 |
Fatty liver
|
1 |
Hepatic encephalopathy (1-3)
|
1 |
Ascites (1-3)
|
1 |
TBIL (μmol/L)
|
1 |
ALB (g/L)
|
1 |
INR
|
1 |
Score
|
5 |
Child-Pugh stage
|
A |
HBV integration detection
|
No |
Integration number
|
0 |
HBV subtype frequency
|
None |
|
|